The Effectiveness of Aspirin for Venous Thromboembolism Prophylaxis for Patients Undergoing Arthroscopic Rotator Cuff Repair.
Adult
Aged
Aged, 80 and over
Arthroscopy
Aspirin
/ therapeutic use
Case-Control Studies
Female
Humans
Male
Middle Aged
Platelet Aggregation Inhibitors
/ therapeutic use
Postoperative Complications
/ etiology
Pulmonary Embolism
/ etiology
Retrospective Studies
Rotator Cuff Injuries
/ surgery
Venous Thromboembolism
/ etiology
Young Adult
Journal
Orthopedics
ISSN: 1938-2367
Titre abrégé: Orthopedics
Pays: United States
ID NLM: 7806107
Informations de publication
Date de publication:
01 Mar 2019
01 Mar 2019
Historique:
received:
18
04
2018
accepted:
17
08
2018
pubmed:
3
1
2019
medline:
17
5
2019
entrez:
3
1
2019
Statut:
ppublish
Résumé
Venous thromboembolic disease (VTED) is a rare complication following arthroscopic rotator cuff repair (RCR). The American Academy of Orthopaedic Surgeons and the American College of Chest Physicians have no prophylaxis guidelines specific to shoulder arthroscopy, yet many surgeons prescribe aspirin following RCR. The purpose of this study was to evaluate the effectiveness of aspirin and mechanical prophylaxis compared with mechanical prophylaxis alone in preventing VTED following RCR. A total of 914 patients underwent RCR between January 2010 and January 2015. A retrospective case-control study was performed. The control group (n=484) consisted of patients treated with compression boots and early mobilization. The study group (n=430) used compression boots, early mobilization, and 81 mg/d of aspirin. The primary outcome was symptomatic VTED, including deep venous thrombosis (DVT) and pulmonary embolism (PE). A total of 7 VTED events occurred during the study period: 6 DVTs and 1 PE; 1 patient experienced both DVT and PE. The percentage of patients with VTED, DVT, and PE was 0.66%, 0.66%, and 0.11%, respectively. There was no significant difference for DVT or PE between the 2 groups. The incidence of DVT and PE was 0.62% and 0.00%, respectively, for the control group (no aspirin) and 0.70% and 0.23%, respectively, for the study group (aspirin). Aspirin does not lead to a clinically significant reduction in either DVT or PE rate in patients undergoing RCR. The authors conclude that the use of mechanical prophylaxis and early mobilization is a sufficient method of VTED prophylaxis in this low-risk population. [Orthopedics. 2019; 42(2):e187-e192.].
Identifiants
pubmed: 30602049
doi: 10.3928/01477447-20181227-05
doi:
Substances chimiques
Platelet Aggregation Inhibitors
0
Aspirin
R16CO5Y76E
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e187-e192Informations de copyright
Copyright 2018, SLACK Incorporated.